Epimed Launches "Cobra" Dual Use Radiofrequency Cannula
Device allows injectate delivery with R-F probe in place
DALLAS, Jan. 17, 2019 /PRNewswire-PRWeb/ -- Epimed International is excited to announce its latest product, the Cobra R-F Dual Use Cannula. The unique approach for this integrated design allows physicians to deliver desired injectates with the R-F probe in place. Studies have shown that lesioning after injecting has been shown to create a larger lesion size, thus improving procedure results and reducing pain for patients.
"After decades of experience with radiofrequency treatments, we developed this device specifically for physicians to complete R-F procedures more efficiently while reducing risk," says Epimed President and CEO Gabor J. Racz. "We're excited about the enhanced level of care this product provides for our customers and their patients."
Using the Cobra, the RF electrode stays in the cannula while injectate is administered, reducing the risk of needle tip migration. This convenient device saves procedure time by allowing physicians to simultaneously inject while lesioning.
Healthcare professionals can learn more about the Cobra R-F Cannula at: https://www.epimed.com/products/cobra-r-f/
About Epimed: Our focus is on developing solutions for experts in Pain Management, Regional Anesthesia and OEM manufacturing. We provide high-quality, effective products to assist with the treatment of acute and chronic pain. Epimed International is a world-wide resource for OEM manufacturing with sites located in upstate New York and Dallas, Texas. We develop specialty devices and services for small scale innovators to Fortune 500 companies with an increasing customer base in Europe, North America, South America and Asia. Additionally, our staff supports continuing education of physicians with a focus on patient safety and participates in local, national, and international meetings and workshops. Epimed has been a lifetime contributor in live surgeries and workshops to help physicians treat chronic and acute pain while developing and sponsoring clinical studies.
If you would like more information about the Cobra R-F Dual Use Cannula or any Epimed products, please contact Paul Hyso at (972) 373-9090 or email [email protected]
SOURCE Epimed
Share this article